Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

Amino acid pharmacokinetics and safety assessmentBIER, Dennis M.The Journal of nutrition. 2003, Vol 133, Num 6, pp 2034-2039, issn 0022-3166, 6 p., SUP1Conference Paper

Role of Microdialysis in Pharmacokinetics and Pharmacodynamics: Current Status and Future DirectionsAZEREDO, Francine Johansson; COSTA, Teresa Dalla; DERENDORF, Hartmut et al.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 205-212, issn 0312-5963, 8 p.Article

On the prediction of the human response : A recycled mechanistic pharmacokinetic/pharmacodynamic approachMENO-TETANG, Guy M. L; LOWE, Philip J.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 182-192, issn 1742-7835, 11 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating AgentsDOSHI, Sameer; KRZYZANSKI, Wojciech; YUE, Susan et al.Clinical pharmacokinetics. 2013, Vol 52, Num 12, pp 1063-1083, issn 0312-5963, 21 p.Article

Development ofTranslational Pharmacokinetic-Pharmacodynamic ModelsMAGER, D. E; JUSKO, W. J.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 6, pp 909-912, issn 0009-9236, 4 p.Article

Pharmacokinetic/pharmacodynamic modelling in oncological drug developmentKARLSSON, Mats O; ANEHALL, Therese; FRIBERG, Lena E et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 206-211, issn 1742-7835, 6 p.Article

Pharmacokinetic-pharmacodynamic modelling : History and perspectivesCSAJKA, Chantal; VEROTTA, Davide.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 3, pp 227-279, issn 1567-567X, 53 p.Article

Antibody pharmacokinetics and pharmacodynamicsLOBO, Evelyn D; HANSEN, Ryan J; BALTHASAR, Joseph P et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 11, pp 2645-2668, issn 0022-3549, 24 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of the Novel SGLT2 Inhibitor IpragliflozinKADOKURA, Takeshi; WENHUI ZHANG; KRAUWINKEL, Walter et al.Clinical pharmacokinetics. 2014, Vol 53, Num 11, pp 975-988, issn 0312-5963, 14 p.Article

Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer AgentsCARON, W. P; SONG, G; KUMAR, P et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 5, pp 802-812, issn 0009-9236, 11 p.Article

Impact of pharmacokinetic-pharmacodynamic model linearization on the accuracy of population information matrix and optimal designMERLE, Yann; TOD, Michel.Journal of pharmacokinetics and biopharmaceutics. 2001, Vol 28, Num 4, pp 363-388, issn 0090-466XArticle

Monoclonal Antibody Pharmacokinetics and PharmacodynamicsWANG, W; WANG, E. Q; BALTHASAR, J. P et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 5, pp 548-558, issn 0009-9236, 11 p.Article

Species differences in Troxacitabine pharmacokinetics and pharmacodynamics: Implications for clinical developmentGOURDEAU, Henriette; LEBLOND, Lorraine; HAMELIN, Bettina et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7692-7702, issn 1078-0432, 11 p.Article

Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric PatientsYEE, Donald L; O'BRIEN, Sarah H; YOUNG, Guy et al.Clinical pharmacokinetics. 2013, Vol 52, Num 11, pp 967-980, issn 0312-5963, 14 p.Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Pharmacokinetic/pharmacodynamic relationships: Basic conceptsTROCONIZ, I. F.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, pp 125-126, issn 0379-0355, 2 p., SUPDConference Paper

Bioequivalence and generic prescribing : an industrial viewPIDGEN, A.Journal of pharmacy and pharmacology. 1996, Vol 48, Num 1, pp 11-16, issn 0022-3573Conference Paper

Clinical Pharmacokinetics and Pharmacodynamics of LinagliptinGRAEFE-MODY, Ulrike; RETLICH, Silke; FRIEDRICH, Christian et al.Clinical pharmacokinetics. 2012, Vol 51, Num 7, pp 411-427, issn 0312-5963, 17 p.Article

Losmapimod concentration―QT relationship in healthy volunteers: meta-analysis of data from six clinical trialsSHUYING YANG; BEERAHEE, Misba.European journal of clinical pharmacology. 2013, Vol 69, Num 6, pp 1261-1267, issn 0031-6970, 7 p.Article

Chemical properties of antiepileptic drugs (AEDs)BIALER, Meir.Advanced drug delivery reviews. 2012, Vol 64, Num 10, pp 887-895, issn 0169-409X, 9 p.Article

Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjectsLIEM-MOOLENAAR, Marieke; DE BOER, Peter; TIMMERS, Maarten et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 886-898, issn 0306-5251, 13 p.Article

Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applicationsMANGONI, A. A; JACKSON, S. H. D.British journal of clinical pharmacology. 2004, Vol 57, Num 1, pp 6-14, issn 0306-5251, 9 p.Article

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes MellitusLANDERSDORFER, Cornelia B; JUSKO, William J.Clinical pharmacokinetics. 2008, Vol 47, Num 7, pp 417-448, issn 0312-5963, 32 p.Article